SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-20-002603
Filing Date
2020-02-07
Accepted
2020-02-07 16:18:10
Documents
3
Period of Report
2020-02-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K nc10008465x1_8k.htm 8-K 14501
2 EXHIBIT 5.1 nc10008465x1_ex5-1.htm EX-5.1 9943
3 nc10008465x1_logo.jpg GRAPHIC 28720
  Complete submission text file 0001140361-20-002603.txt   65349
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 20587687
SIC: 2836 Biological Products, (No Diagnostic Substances)